{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:59:44Z","timestamp":1786121984341,"version":"build-2736575974"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.humpath.2026.106098","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:07:26Z","timestamp":1772557646000},"page":"106098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Syndromes Aassociated with Lipomatous Tumors (SALT): A comprehensive review"],"prefix":"10.1016","volume":"175","author":[{"given":"Erica Y.","family":"Kao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre M.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.humpath.2026.106098_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2021.104077","article-title":"Multiple symmetric and multiple familial lipomatosis","volume":"50","author":"Lemaitre","year":"2021","journal-title":"Presse Med"},{"issue":"3","key":"10.1016\/j.humpath.2026.106098_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00266-020-02083-5","article-title":"Madelung disease epidemiology and clinical characteristics: a systemic review","volume":"45","author":"Liu","year":"2021","journal-title":"Aesthetic Plast Surg"},{"issue":"1","key":"10.1016\/j.humpath.2026.106098_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00131402-200309000-00001","article-title":"Multiple symmetric lipomatosis (Madelung's disease) caused by the MERRF (A8344G) mutation: two cases and review","volume":"5","author":"Chong","year":"2003","journal-title":"J Clin Neuromuscul Dis"},{"issue":"18","key":"10.1016\/j.humpath.2026.106098_bib4","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1093\/hmg\/ddv229","article-title":"Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy","volume":"24","author":"Sawyer","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.humpath.2026.106098_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/WNL.51.1.258","article-title":"Familial multiple symmetric lipomatosis associated with the A8344G mutation of mitochondrial DNA","volume":"51","author":"G\u00e1mez","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.humpath.2026.106098_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5114\/ada.2023.129529","article-title":"Lipomas: genetic basis of common skin lesions and their occurrence in rare diseases","volume":"40","author":"Marzy\u0144ska","year":"2023","journal-title":"Postepy Dermatol Alergol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106098_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ando.2024.05.003","article-title":"Lipomatoses","volume":"85","author":"Dupuis","year":"2024","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.humpath.2026.106098_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CCID.S213139","article-title":"Clinical and molecular investigation of familial multiple lipomatosis: variants in the HMGA2 gene","volume":"13","author":"Mej\u00eda","year":"2020","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106098_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.hemonc.2016.01.001","article-title":"A rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased predilection to cancers","volume":"9","author":"Reddy","year":"2016","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"6","key":"10.1016\/j.humpath.2026.106098_bib10","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/jcm10061292","article-title":"Rare forms of lipomatosis: dercum's disease and roch-leri mesosomatous lipomatosis","volume":"10","author":"Lemaitre","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.humpath.2026.106098_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-7-23","article-title":"Review of Dercum's disease and proposal of diagnostic criteria, diagnostic methods, classification and management","volume":"7","author":"Hansson","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.humpath.2026.106098_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1067\/mjd.2001.110872","article-title":"Familial occurrence of adiposis dolorosa","volume":"44","author":"Campen","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2026.106098_bib13","series-title":"Endotext [Internet]","article-title":"Subcutaneous adipose tissue diseases: dercum disease, lipedema, familial multiple lipomatosis, and Madelung disease","author":"Herbst","year":"2019"},{"issue":"9","key":"10.1016\/j.humpath.2026.106098_bib14","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ng2113","article-title":"Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype","volume":"39","author":"Brems","year":"2007","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.humpath.2026.106098_bib15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"issue":"19","key":"10.1016\/j.humpath.2026.106098_bib16","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/jama.2009.1663","article-title":"Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome","volume":"302","author":"Messiaen","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.humpath.2026.106098_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2302\/kjm.2013-0002-RE","article-title":"Legius syndrome, an Update. Molecular pathology of mutations in SPRED1","volume":"62","author":"Brems","year":"2013","journal-title":"Keio J Med"},{"issue":"27","key":"10.1016\/j.humpath.2026.106098_bib18","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198112313052704","article-title":"Von Recklinghausen neurofibromatosis","volume":"305","author":"Riccardi","year":"1981","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.humpath.2026.106098_bib19","first-page":"e371","article-title":"Cutaneous manifestations in neurofibromatosis type 1","volume":"171","author":"Miraglia","year":"2020","journal-title":"Clin Ter"},{"issue":"7","key":"10.1016\/j.humpath.2026.106098_bib20","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/humu.24022","article-title":"Null phenotype of neurofibromatosis type 1 in a carrier of a heterozygous atypical NF1 deletion due to mosaicism","volume":"41","author":"Kluwe","year":"2020","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.humpath.2026.106098_bib21","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000582","article-title":"Familial lipomas without classic Neurofibromatosis-1 caused by a missense germline NF1 mutation","volume":"7","author":"Ramirez","year":"2021","journal-title":"Neurol Genet"},{"issue":"7","key":"10.1016\/j.humpath.2026.106098_bib22","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/MCG.0000000000000248","article-title":"Increased prevalence of Subcutaneous Lipomas in patients with Wilson disease","volume":"49","author":"Schaefer","year":"2015","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.humpath.2026.106098_bib23","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1210\/jc.2004-0218","article-title":"Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1","volume":"89","author":"Asgharian","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.humpath.2026.106098_bib24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1468-3083.2008.02578.x","article-title":"Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1","volume":"22","author":"Vidal","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"18","key":"10.1016\/j.humpath.2026.106098_bib25","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/MCB.01001-08","article-title":"The MEN1 tumor suppressor regulates PPAR\u03b3-dependent adipocyte differentiation","volume":"29","author":"Dreijerink","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106098_bib26","first-page":"10","article-title":"Adrenal liposarcoma: a novel presentation of multiple Endocrine Neoplasia type 1","volume":"9","author":"Duro","year":"2022","journal-title":"AACE Clin Case Rep"},{"issue":"3","key":"10.1016\/j.humpath.2026.106098_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ando.2017.03.001","article-title":"Hibernoma and multiple endocrine neoplasia type 1 syndrome: a non-fortuitous association? A case report and literature review","volume":"78","author":"Marchand","year":"2017","journal-title":"Ann Endocrinol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106098_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.23922\/jarc.2023-028","article-title":"Clinical guidelines for diagnosis and management of Cowden Syndrome\/PTEN hamartoma tumor syndrome in children and adults-secondary publication","volume":"7","author":"Takayama","year":"2023","journal-title":"J Anus Rectum Colon"},{"issue":"2","key":"10.1016\/j.humpath.2026.106098_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1067\/mjd.2001.110390","article-title":"Identification of a PTEN mutation in a family with Cowden syndrome and Bannayan-Zonana syndrome","volume":"44","author":"Wanner","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.humpath.2026.106098_bib30","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jpedsurg.2006.05.013","article-title":"Cutaneous lipoma in children: 5 cases with bannayan-riley-ruvalcaba syndrome","volume":"41","author":"Buisson","year":"2006","journal-title":"J Pediatr Surg"},{"issue":"5","key":"10.1016\/j.humpath.2026.106098_bib31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/pde.14265","article-title":"Groupe de Recherche de la Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie P\u00e9diatrique. Cutaneous lipomas and macrocephaly as early signs of PTEN hamartoma tumor syndrome","volume":"37","author":"Martin","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106098_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0090-3019(98)00039-1","article-title":"Bannayan-Zonana syndrome: a rare autosomal dominant syndrome with multiple lipomas and hemangiomas: a case report and review of literature","volume":"50","author":"Gujrati","year":"1998","journal-title":"Surg Neurol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106098_bib33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/modpathol.2017.161","article-title":"Intramucosal lipomas of the colon implicate Cowden syndrome","volume":"31","author":"Caliskan","year":"2018","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2026.106098_bib34","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/modpathol.3800448","article-title":"Testicular lipomatosis in Cowden's syndrome","volume":"18","author":"Woodhouse","year":"2005","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2026.106098_bib35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1510\/icvts.2010.245001","article-title":"Right atrial lipoma in patient with Cowden syndrome","volume":"11","author":"Ceresa","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.humpath.2026.106098_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41525-017-0039-y","article-title":"Germline TTN variants are enriched in PTEN-wildtype bannayan-riley-ruvalcaba syndrome","volume":"2","author":"Yehia","year":"2017","journal-title":"npj Genom Med"},{"issue":"1","key":"10.1016\/j.humpath.2026.106098_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-0033-1343078","article-title":"Proteus syndrome: report of intra-abdominal lipomatosis","volume":"1","author":"Erginel","year":"2013","journal-title":"European J Pediatr Surg Rep"},{"issue":"7","key":"10.1016\/j.humpath.2026.106098_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1104017","article-title":"A mosaic activating mutation in AKT1 associated with Proteus syndrome","volume":"365","author":"Lindhurst","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.humpath.2026.106098_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajmg.a.36773","article-title":"Myocardial fat overgrowth in Proteus syndrome","volume":"167A","author":"Hannoush","year":"2015","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.humpath.2026.106098_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/cge.12266","article-title":"Proteus syndrome review: molecular, clinical, and pathologic features","volume":"85","author":"Cohen","year":"2014","journal-title":"Clin Genet"},{"issue":"3","key":"10.1016\/j.humpath.2026.106098_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/cge.14174","article-title":"Progressive frontal intraosseous lipoma: detection of the mosaic AKT1 variant discloses Proteus syndrome","volume":"102","author":"Schmidt","year":"2022","journal-title":"Clin Genet"},{"issue":"12","key":"10.1016\/j.humpath.2026.106098_bib42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.39.12.937","article-title":"Germline mutation of the tumour suppressor PTEN in Proteus syndrome","volume":"39","author":"Smith","year":"2002","journal-title":"J Med Genet"},{"issue":"9277","key":"10.1016\/j.humpath.2026.106098_bib43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(01)05412-5","article-title":"Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes","volume":"358","author":"Zhou","year":"2001","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.humpath.2026.106098_bib44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jmg.38.7.480","article-title":"PTEN mutations are uncommon in Proteus syndrome","volume":"38","author":"Barker","year":"2001","journal-title":"J Med Genet"},{"issue":"8","key":"10.1016\/j.humpath.2026.106098_bib45","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway","volume":"96","author":"Cantley","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.humpath.2026.106098_bib46","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ajmg.a.36552","article-title":"Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum","volume":"164A","author":"Keppler-Noreuil","year":"2014","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.humpath.2026.106098_bib47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.36836","article-title":"PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation","volume":"167A","author":"Keppler-Noreuil","year":"2015","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.humpath.2026.106098_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cge.12832","article-title":"CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS)","volume":"91","author":"Martinez-Lopez","year":"2017","journal-title":"Clin Genet"},{"issue":"6","key":"10.1016\/j.humpath.2026.106098_bib49","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.05.006","article-title":"Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome","volume":"90","author":"Kurek","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.humpath.2026.106098_bib50","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA","volume":"166","author":"Luks","year":"2015","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.humpath.2026.106098_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63466","article-title":"Molecular characterization of 13 patients with PIK3CA-related overgrowth spectrum using a targeted deep sequencing approach","volume":"194","author":"de Kock","year":"2024","journal-title":"Am J Med Genet"},{"issue":"5","key":"10.1016\/j.humpath.2026.106098_bib52","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41436-018-0297-9","article-title":"Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum","volume":"21","author":"Parker","year":"2019","journal-title":"Genet Med"},{"issue":"12","key":"10.1016\/j.humpath.2026.106098_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100969","article-title":"Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS)","volume":"25","author":"Canaud","year":"2023","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.humpath.2026.106098_bib54","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jmg.2009.066068","article-title":"Encephalocraniocutaneous lipomatosis","volume":"46","author":"Moog","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.humpath.2026.106098_bib55","series-title":"GeneReviews\u00ae [Internet]","article-title":"Encephalocraniocutaneous lipomatosis. 2022 Jan 27","author":"Moog","year":"1993"},{"issue":"7","key":"10.1016\/j.humpath.2026.106098_bib56","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/cup.13663","article-title":"Nevus psiloliparus: newly described histopathological features from transverse sections","volume":"47","author":"Roman","year":"2020","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106098_bib57","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/10935266211040802","article-title":"Expending the phenotypic spectrum of encephalocraniocutaneous lipomatosis: about a prenatal case with complete autopsy","volume":"25","author":"Cattin","year":"2022","journal-title":"Pediatr Dev Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106098_bib58","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ajhg.2016.02.006","article-title":"Mosaic activating mutations in FGFR1 cause encephalocraniocutaneous lipomatosis","volume":"98","author":"Bennett","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.humpath.2026.106098_bib59","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/cge.12775","article-title":"Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis","volume":"90","author":"Boppudi","year":"2016","journal-title":"Clin Genet"},{"issue":"9","key":"10.1016\/j.humpath.2026.106098_bib60","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/ajmg.a.62356","article-title":"Novel findings and expansion of phenotype in a mosaic RASopathy caused by somatic KRAS variants","volume":"185","author":"Chang","year":"2021","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.humpath.2026.106098_bib61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jnci\/89.1.83","article-title":"Hereditary retinoblastoma, lipoma, and second primary cancers","volume":"89","author":"Marees","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2026.106098_bib62","doi-asserted-by":"crossref","first-page":"785","DOI":"10.5999\/aps.2014.41.6.785","article-title":"Retinoblastoma plus lipomatosis: an autosomal dominant syndrome","volume":"41","author":"Choi","year":"2014","journal-title":"Arch Plast Surg"},{"key":"10.1016\/j.humpath.2026.106098_bib63","first-page":"402","article-title":"Benign tumors in long-term survivors of retinoblastoma","volume":"113","author":"Wong","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2026.106098_bib64","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1177\/10668969231157779","article-title":"Anisometric cell\/dysplastic lipomas in a retinoblastoma survivor: case report and review","volume":"31","author":"Malik","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106098_bib65","first-page":"478","article-title":"Dysplastic lipoma: a distinctive atypical lipomatous neoplasm","volume":"52","author":"Creytens","year":"2018","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.humpath.2026.106098_bib66","first-page":"1007","article-title":"The rapidly expanding group of RB1-deleted soft tissue tumors: an updated review","volume":"13","author":"Thway","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.humpath.2026.106098_bib67","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/PAS.0000000000001129","volume":"42","author":"Michal","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106098_bib68","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.anndiagpath.2017.04.012","article-title":"Anisometric cell lipoma: insight from a case series and review of the literature on adipocytic neoplasms in survivors of retinoblastoma suggest a role for RB1 loss and possible relationship to fat-predominant (\"fat-only\") spindle cell lipoma","volume":"29","author":"Agaimy","year":"2017","journal-title":"Ann Diagn Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2026.106098_bib69","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1177\/1066896920939657","article-title":"\"Dysplastic Lipoma\" is probably not a separate entity but rather belongs to the morphological spectrum of atypical spindle cell\/pleomorphic lipomatous tumor","volume":"28","author":"Creytens","year":"2020","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106098_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2045-3329-2-15","article-title":"Sarcomas in hereditary retinoblastoma","volume":"2","author":"Kleinerman","year":"2012","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.humpath.2026.106098_bib71","article-title":"Incidence of second primary cancers in patients with retinoblastoma: a systematic review and meta-analysis","volume":"14","author":"Sun","year":"2024","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106098_bib72","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-0036-1579759","article-title":"Li-Fraumeni syndrome","volume":"5","author":"Correa","year":"2016","journal-title":"J Pediatr Genet"},{"issue":"5","key":"10.1016\/j.humpath.2026.106098_bib73","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00383-017-4063-x","article-title":"Pleomorphic myxoid liposarcoma in an adolescent with Li-Fraumeni syndrome","volume":"33","author":"Sinclair","year":"2017","journal-title":"Pediatr Surg Int"},{"issue":"10","key":"10.1016\/j.humpath.2026.106098_bib74","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: growing ever more complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.humpath.2026.106098_bib75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/his.12913","article-title":"Comprehensive genetic analysis of a paediatric pleomorphic myxoid liposarcoma reveals near-haploidization and loss of the RB1 gene","volume":"69","author":"Hofvander","year":"2016","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.humpath.2026.106098_bib76","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41379-022-01107-6","article-title":"Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study","volume":"35","author":"Dermawan","year":"2022","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2026.106098_bib77a","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41379-021-00862-2","article-title":"Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma","volume":"34","author":"Creytens","year":"2021","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106098_bib77b","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41366-020-00716-y","article-title":"Reduced lipolysis in lipoma phenocopies lipid accumulation in obesity","volume":"45","author":"Le Duc","year":"2021","journal-title":"Int J Obes"},{"issue":"3","key":"10.1016\/j.humpath.2026.106098_bib78","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41366-020-00716-y","article-title":"Reduced lipolysis in lipoma phenocopies lipid accumulation in obesity","volume":"45","author":"Le","year":"2021","journal-title":"Int J Obes"},{"key":"10.1016\/j.humpath.2026.106098_bib79","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40575-018-0065-9","article-title":"Lipoma in dogs under primary veterinary care in the UK: prevalence and breed associations","volume":"5","author":"O'Neill","year":"2018","journal-title":"Canine Genet Epidemiol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106098_bib80","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/10406387251328600","article-title":"Cutaneous and subcutaneous fibrolipomas in 236 dogs, 2017-2024: a retrospective case series and comparative review","volume":"37","author":"Mendes","year":"2025","journal-title":"J Vet Diagn Invest"},{"issue":"3","key":"10.1016\/j.humpath.2026.106098_bib81","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/030098588001700305","article-title":"Infiltrative lipoma in dogs","volume":"17","author":"McChesney","year":"1980","journal-title":"Vet Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106098_bib82","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.cmet.2016.04.012","article-title":"A deletion in the canine POMC gene is associated with weight and appetite in obesity-prone labrador retriever dogs","volume":"23","author":"Raffan","year":"2016","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.humpath.2026.106098_bib83","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0165-4608(98)00231-3","article-title":"Cytogenetic investigation of canine lipomas","volume":"111","author":"Reimann","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"issue":"11","key":"10.1016\/j.humpath.2026.106098_bib84","doi-asserted-by":"crossref","DOI":"10.1177\/1098612X241285519","article-title":"Overweight and obesity in domestic cats: epidemiological risk factors and associated pathologies","volume":"26","author":"Saavedra","year":"2024","journal-title":"J Feline Med Surg"},{"issue":"1","key":"10.1016\/j.humpath.2026.106098_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76166-3","article-title":"Mapping the genetic basis of diabetes mellitus in the Australian Burmese cat (Felis catus)","volume":"10","author":"Samaha","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.humpath.2026.106098_bib86","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/age.13335","article-title":"Melanocortin-4 receptor and proopiomelanocortin: candidate genes for obesity in domestic shorthair cats","volume":"54","author":"Jerjen","year":"2023","journal-title":"Anim Genet"},{"issue":"19","key":"10.1016\/j.humpath.2026.106098_bib87","doi-asserted-by":"crossref","first-page":"14394","DOI":"10.1074\/jbc.M000564200","article-title":"Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas","volume":"275","author":"Arlotta","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.humpath.2026.106098_bib88","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1086\/427565","article-title":"Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas","volume":"76","author":"Ligon","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.humpath.2026.106098_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100956","article-title":"Genetically engineered mouse model of pleomorphic liposarcoma: immunophenotyping and histologic characterization","volume":"48","author":"Brown","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.humpath.2026.106098_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151454","article-title":"Aged mice overexpressing cellular repressor of E1A-stimulated genes 1 in adipose tissues exhibited increased liposarcoma incidence and shortened lifespan","volume":"753","author":"Hashimoto","year":"2025","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:13:38Z","timestamp":1786090418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":91,"alternative-id":["S0046817726000675"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106098","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndromes Aassociated with Lipomatous Tumors (SALT): A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106098"}}